Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis

Inclusion Criteria: * Patients who are initially sputum smear positive (at least two smears as "1+" or at least have a smear as "2+" and above) or culture-positive for pulmonary tuberculosis who have been treated previously * Aged 18 -65 years of age * Patients who are willing to give written informed consent Exclusion Criteria: * Participation in another clinical trial 1 month prior to study entry * Female patients in lactation period, pregnancy or planning to get pregnant during the trial * Patients who are allergic to the therapeutic medicine * Patients with severe primary diseases such as cancer, cardiovascular system, digestive system, kidney and hematopoietic system diseases * Patients co-infected with HIV, hepatitis B or hepatitis C * Patients with mental illness, acrasia * Abnormal liver function or combined with other underlying liver disease (fatty liver, alcoholic liver) * Patients with diabetes, Plasma glucose poorly controlled undertaking * Patients with auditory dysfunction